Exercise-Mediated Lowering of Glutamine Availability Suppresses Tumor Growth and Attenuates Muscle Wasting
Overview
Authors
Affiliations
Glutamine is a central nutrient for many cancers, contributing to the generation of building blocks and energy-promoting signaling necessary for neoplastic proliferation. In this study, we hypothesized that lowering systemic glutamine levels by exercise may starve tumors, thereby contributing to the inhibitory effect of exercise on tumor growth. We demonstrate that limiting glutamine availability, either pharmacologically or physiologically by voluntary wheel running, significantly attenuated the growth of two syngeneic murine tumor models of breast cancer and lung cancer, respectively, and decreased markers of atrophic signaling in muscles from tumor-bearing mice. In continuation, wheel running completely abolished tumor-induced loss of weight and lean body mass, independently of the effect of wheel running on tumor growth. Moreover, wheel running abolished tumor-induced upregulation of muscular glutamine transporters and myostatin signaling. In conclusion, our data suggest that voluntary wheel running preserves muscle mass by counteracting muscular glutamine release and tumor-induced atrophic signaling.
Untargeted Metabolomics and Proteomics-Based Research of the Long-Term Exercise on Human Body.
Zhuang W, Wang Y, Xu X, Zhao J Appl Biochem Biotechnol. 2025; .
PMID: 39937413 DOI: 10.1007/s12010-025-05195-3.
Li X, Chen Y, Li X, Yang X, Zhou L, Cheng Y Curr Oncol Rep. 2025; .
PMID: 39913071 DOI: 10.1007/s11912-025-01635-9.
Exploring the role of adipokines in exercise-induced inhibition of tumor growth.
Qian Y, Bu Z, Qin Y, Qian S, Qin L, Zhou S Sports Med Health Sci. 2025; 7(2):143-156.
PMID: 39811408 PMC: 11726049. DOI: 10.1016/j.smhs.2024.03.006.
Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.
Duraj T, Kalamian M, Zuccoli G, Maroon J, DAgostino D, Scheck A BMC Med. 2024; 22(1):578.
PMID: 39639257 PMC: 11622503. DOI: 10.1186/s12916-024-03775-4.
Li T, Shao J, An N, Chang Y, Xia Y, Han Q Immun Inflamm Dis. 2024; 12(10):e70030.
PMID: 39352112 PMC: 11443606. DOI: 10.1002/iid3.70030.